Osteoclast-like cells in murine collagen induced arthritis

Journal of Rheumatology

Volumn 25, Issue 6, 1998, Pages 1154-1160

  Suzuki, Yu ^a   Nishikaku, Fumio ^a   Nakatuka, Masashi ^a   Koga, Yoshihiko ^a  

^a DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

Author keywords

Collagen induced arthritis; Joint destruction; Osteoclasts

Indexed keywords

ACID PHOSPHATASE; INDOMETACIN; INTERLEUKIN 6 ANTIBODY; NEUTRALIZING ANTIBODY; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; CELL DIFFERENTIATION; COLLAGEN DISEASE; CONTROLLED STUDY; HISTOGRAM; HISTOLOGY; MALE; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS;

ACID PHOSPHATASE; ANIMALS; ARTHRITIS, EXPERIMENTAL; BONE RESORPTION; CELL COUNT; CELLS, CULTURED; COLLAGEN; DINOPROSTONE; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HINDLIMB; INDOMETHACIN; INTERLEUKIN-1; INTERLEUKIN-6; ISOENZYMES; MALE; MICE; MICE, INBRED DBA; NEUTRALIZATION TESTS; OSTEOCLASTS; TARSAL JOINTS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031823129     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Bromley M, Woolley DE. Histopathology of the rheumatoid lesion: identification of cell types at sites of cartilage erosion. Arthritis Rheum 1984;27:857-63.
2. Shiozawa S, Shiozawa K, Fujita T. Morphologic observations in the early phase of the cartilage-pannus junction: light and electron microscopic studies of active cellular pannus. Arthritis Rheum 1983;26:472-8.
3. Kobayashi I, Ziff M. Electron microscopic studies of the cartilage-pannus junction in rheumatoid arthritis. Arthritis Rheum 1975;18:475-83.
4. Leisen JCC, Duncan H, Riddle JM, Richford WC. The erosive front: A topographic study of the junction between the pannus and the subchondral plate in the macerated rheumatoid metacarpal head. J Rheumatol 1988;15:17-22.
5. Ishikawa H, Ohono O, Hirohata K. An electron microscopic study of the synovial-bone junction in rheumatoid arthritis. Rheumatol Int 1984;4:1-8.
6. Takashima T, Kawai K, Hirohata K, Miki A, Mizoguchi H. Cooke TDV. Inflammatory cell changes in haversian canals: a possible cause of osteoporosis in rheumatoid arthritis. J Bone Joint Surg 1989;71B:671-6.
7. Bromley M, Bertfield H, Evanson JM, Woolley DE. Bidirectional erosion of cartilage in rheumatoid knee joint. Ann Rheum Dis 1985;44:676-81.
8. Bromley M, Woolley DE. Chondroclasts and osteoclasts at subchondral sites of erosion in the rheumatoid joint. Arthritis Rheum 1984;27:968-75.
9. Mohr W, Menninger H. Polymorphonuclear granulocytes at the pannus-cartilage joint in rheumatoid arthritis [letter]. Arthritis Rheum 1980;23:1413-4.
10. Mohr W, Wessinghage D. The relationship between polymorphonuclear granulocytes and cartilage destruction in rheumatoid arthritis. Z Rheumatol 1978;37:81-6.
11. Robinson DR, McGuire MB. Prostaglandins in the rheumatic diseases. Ann NY Acad Sci 1975;256:318-29.
12. 2-stimulated bone resorption. Lab Invest 1980;42:290-5.
13. Robinson DR, Tashjian AHJ, Levine L. Prostaglandin-stimulated bone resorption by rheumatoid synovia: a possible mechanism for bone destruction in rheumatoid arthritis. J Clin Invest 1975;56:1181-8.
14. Miyasaka N, Sato K, Goto M, et al. Augumented interleukin-1 production and HLA-DR expression in synovium of rheumatoid arthritis patients: possible involvement in joint destruction. Arthritis Rheum 1988;31:480-6.
15. Miyasaka N, Sato K, Hashimoto J, et al. Constitutive production of interleukin 6/B cell stimulatory factor-2 from inflammatory synovium. Clin Immunol Immunopathol 1989;52:238-47.
16. Buchan G, Barrett K, Turner M, Chantry D, Maini RN, Feldmann M. Interleukin-1 and tumour necrosis factor mRNA expression in rheumatoid arthritis: prolonged production of IL-1a. Clin Exp Immunol 1988;73:449-55.
17. Brennan FM, Chantry D, Jackson A, Maini RN, Feldmann M. Inhibitory effect of TNF-α antibodies on synovial cell interleukin-1 production in rheumatoid arthritis. Lancet 1989;11:224-7.
18. Chu CQ, Field M, Feldmann M, Maini RN. Localization of tumor necrosis factor a in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis. Arthritis Rheum 1991;34:1125-32.
19. Trentham ED, Townes AS, Kang AH. Autoimmunity to type II collagen: an experimental model of arthritis. J Exp Med 1977;146:857-69.
20. Bjork J, Kleinau S. Paradoxical effects of LS-2661 (linomide) treatment in the type II collagen arthritis model in mice. Agents Actions 1989;27:319-21.
21. Barka T, Anderson PJ. Histochemical method for acid phosphatase using hexasonium pararosaniline as coupler. J Histochem Cytochem 1962;10:741-53.
22. Takada Y, Kusuda M, Hiura K, et al. A simple method to assess osteoclast-mediated bone resorption using unfractionated bone cells. Bone and Mineral 1992;17:347-59.
23. Akatsu T, Takahashi N, Debari K, et al. Prostaglandins promote osteoclast-like cell formation by a mechanism involving cyclic adenosine 3′,5′-monophosphate in mouse bone marrow cell cultures. J Bone Miner Res 1989;4:29-35.
24. Collins DA, Chambers TJ. Effect of prostaglandins E1, E2, and F2a on osteoclast formation in mouse marrow cultures. J Bone Miner Res 1991;6:157-64.
25. Kotake S, Sato K, Kim KJ, et al. Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation. J Bone Miner Res 1996;11:88-95.
26. Anderson GD, Hauser SD, McGarity KL, Bremer ME, Isakson PC, Gregory SA. Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis. J Clin Invest 1996;97:2672-9.
27. Portanova BJP, Zhang Y, Andersen GD, et al. Selective neutralization of prostaglandin E2 blocks inflammation, hyperalgesia, and interleukin 6 production in vivo. J Exp Med 1996;184:883-91.
28. Ikebuchi K, Wong GG, Clark SC, et al. Interleukin 6 enhancement of interleukin 3-dependent proliferation of multipotential hemopoietic progenitors. Proc Natl Acad Sci USA 1987;84:9035-9.
29. Ikebuchi K, Ihle JN, Hirai Y, et al. Synergistic factors for stem cell proliferation; further studies of the target stem cell and mechanism of stimulation by interleukin-1, interleukin-6, and granulocyte colony-stimulating factor. Blood 1988;72:2007-14.
30. Roodman GD. Interleukin-6: An osteotropic factor? J Bone Miner Res 1992;7:475-8.
31. Suda T, Takahashi N, Martin TJ. Modulation of osteoclast differentiation. Endocr Rev 1992;13:66-80.
32. Kitazawa R, Kimble RB, Vannice JL, Kung VT, Pacifici R. Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice. J Clin Invest 1994;94:2397-406.
33. Suzuki Y, Tanihara M, Ichikawa Y, et al. Periarticular osteopenia in adjuvant induced arthritis: role of interleukin-1 in decreased osteogenic and increased resorptive potential of bone marrow cells. Ann Rheum Dis 1995;54:484-90.
34. Williams Ro, Feldmann M, Maini RN. Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis. Proc Natl Acad Sci USA 1992;89:9784-8.
35. Mauri C, Williams RO, Walmsley M, Feldmann M. Relationship between Th1/Th2 cytokine patterns and the arthritogenic response in collagen-induced arthritis. Eur J Immunol 1996;26:1511-8.
36. Joosten LAB, Helsen MMA, Loo FAJVD, Berg WBVD. Anticytokine treatment of established type II collagen-induced arthritis in DBA/1j mice. Arthritis Rheum 1996;39:797-809.
37. Stasiuk LM, Abehsiraamar O, Fournier C. Collagen-induced arthritis in DBA/1 mice: cytokine gene activation following immunization with type II collagen. Cell Immunol 1996;173:269-75.